Skip to main content Help with accessibility Skip to main navigation

TOFACITINIB film-coated tablets (Xeljanz®▼) for Psoriatic Arthritis

Last Updated: 30 November 2018

Body System: Musculoskeletal system


The Pan Mersey Area Prescribing Committee recommends the prescribing of TOFACITINIB tablets (Xeljanz®▼), by specialists only, for treating psoriatic arthritis after inadequate response to DMARDs in accordance with NICE TA543.